📅 8 July 2026
🕒 16:00 – 17:00 (CEST)
We kindly invite you for the meeting 'JA PCM Private Sector: Contribution Briefing & Initial Discussion'.
The Joint Action on Personalised Cancer Medicine (JA PCM) is engaging private sector partners to collaborate on the project’s pilot activities, and to support the development of a sustainable framework for public-private collaboration in personalised cancer medicine.
This session builds on the previous JA PCM webinar, "Private Sector Engagement: Opportunities & Next Steps", which took place on 26 May.
The session will cover:
- An overview of the upcoming Contribution Procedure, explaining how private sector partners can formally engage with JA PCM pilot activities.
- An initial, open discussion to gather private sector perspectives on developing a collaborative framework for long-lasting public-private collaboration in the field of precision oncology.
The session marks an initial step in an ongoing dialogue between JA PCM and the private sector. By joining the session, you will be able to share input that will directly contribute to the development of the collaborative private sector framework.
Who should attend
Across cancer diagnostics, therapeutics, digital health and related services from the life sciences and health industry field, we particularly welcome colleagues working in Medical and Clinical Affairs, Translational Research, Real-World Evidence, Health Economics and Outcomes Research, Health Technology Assessment, Market Access, Business Development and Strategic Partnerships, and EU Policy and Government Affairs.
Do not hesitate to share the invitation with anyone who might be interested!